In the News

413 News Items found
electron micrograph of a natural killer cell
In the Lab
A drug combination that halts tumor cell division can stir the immune system into taking action.
Dr. Prasad Adusumilli sits at a computer. A patient’s face and a chest image are on the screen.
Feature
Whether you’ve been diagnosed with a rare cancer or one that’s more common, MSK doctors can provide a second opinion.
Graphic showing 11 cancer drugs approved by the FDA based on significant work done at MSK
The U.S. Food and Drug Administration (FDA) approved 11 cancer drugs in 2024 based on significant contributions from MSK researchers.
MSK surgeons gathered around a robot used for cancer surgery
Q&A
Department of Surgery Chair Jeffrey Drebin discusses MSK’s approach to robotic surgery in response to a recent FDA advisory.
Gloved hands hold several test tubes of blood with a piece of lab equipment in the background
Learn how blood tests called liquid biopsies may be used to find, diagnose, and treat cancer anywhere in the body.
Memorial Sloan Kettering Ralph Lauren Center nurse Jasmine Gibson, breast cancer patient Maria Tucker, and nurse Margaret Bediones
See how experts at Memorial Sloan Kettering Cancer Center's Ralph Lauren Center cared for Maria close to home.
Immunotherapy is a powerful tool against cancer. How does it work? Who can it help? MSK expert Dr. Michael Postow has answers
Treating Cancer With Immunotherapy: FAQ
Learn the most frequently asked questions about immunotherapy, a form of cancer treatment that uses the body's own immune system to overpower cancer cells. Learn who it can help, how it works, and how experts at MSK are finding ways to make it benefit more people, including new combinations with other cancer treatments like chemotherapy, surgery, radiation and more.
CAR T cell therapy
In the Clinic
Cell therapies that use patients’ own immune cells to attack cancer — including CAR T cell therapy, an approach developed at MSK — are a promising and rapidly growing area of research.
Dr. Alicia Latham, Dr. Michael Walsh, Dr. Zsofia Stadler, and Megha Ranganathan
Feature
MSK investigators are leading research focused on understanding how hereditary DNA mutations affect cancer development and therapy, and how to best treat people who carry these inherited risks in their genes.
Dr. Rosa Nouvini seen smiling outdoors.
Learn from an MSK expert about screening in the Latino community for colorectal cancer, to help prevent the disease.